Trials / Completed
CompletedNCT00956878
Cancer Pain Single Nucleotide Polymorphisms (SNPs)
Storage and Analysis of Patient Blood-samples for Cancer Pain Research
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 243 (actual)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cancer pain is common in advanced cancer patients. Opioids are the mainstay of treatment in cancer pain. Responsiveness to and tolerability of opioids is, amongst others, determined by small variations in human DNA. Using blood samples from clinically well-defined cancer pain patients, the investigators are going to analyze single nucleotide polymorphisms (SNPs) in genes that are known to be involved in responsiveness to opioids and sensitivity to pain.
Conditions
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2012-12-01
- Completion
- 2012-12-01
- First posted
- 2009-08-11
- Last updated
- 2014-12-24
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00956878. Inclusion in this directory is not an endorsement.